Homologous Recombination Deficiency and Cancer Care

As with PD-L1, HER2, and EGFR, an understanding of a patient’s HRD status is a critical component of personalized cancer care. Watch the video to learn more about how testing for HRD can help characterize a patient’s tumor and aid in the development of a comprehensive treatment plan.
Visit www.AZprecisionmed.com to learn more.